Product
Placebo Saline Infusion
1 clinical trial
1 indication
Indication
Glioblastoma MultiformeClinical trial
A Phase II Double-blind, RandomizEd, Prospective, Placebo Controlled STudy of NanO2TM Combined With Radiation and Temozolomide in Patients With Newly-diagnosed Glioblastoma multiformE: RESTOREStatus: Recruiting, Estimated PCD: 2025-06-30